unknown
Stage
1
Investors
About
ViraTherapeutics GmbH develops oncolytic virus-based therapies for cancer, engineering viruses to selectively infect and kill tumor cells and stimulate anti-tumor immune responses.
Explore ViraTherapeutics GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.